15 Major Problems and Challenges of Biotechnology: Causes, Disadvantages, Ethical Concerns and Possible Solutions
Biotechnology has become one of the most influential fields in modern science, transforming how humans produce food, develop medicines, improve agriculture, protect the environment and manufacture industrial products. From genetically modified crops and vaccines to gene editing, tissue engineering and advanced medical treatments, biotechnology offers solutions to some of the world's most pressing challenges. However, despite its numerous benefits, the rapid development and application of biotechnology also raise important questions about safety, ethics, environmental sustainability, affordability and accessibility.
What are the major problems and challenges of biotechnology? Can genetically modified organisms negatively affect the environment? Are there potential health risks associated with biotechnology products? What ethical concerns arise from genetic engineering and gene editing? These are some of the questions frequently raised by students, researchers, healthcare professionals, policymakers and members of the general public.
Although biotechnology has the potential to improve human life, its applications are not without limitations. Some technologies require expensive equipment, specialised expertise and advanced research facilities, making them difficult to access in developing countries. Other applications raise concerns about biodiversity, genetic privacy, biological safety, unequal access to scientific advancements and the possibility of unintended consequences.
Understanding these challenges is important because it helps individuals and governments make informed decisions about how biotechnology should be developed, regulated and used. In this article, we examine 15 major problems and challenges of biotechnology, explaining their causes, potential disadvantages, ethical implications and possible solutions. Whether you are a student studying biotechnology, a researcher or simply interested in understanding modern scientific developments, this guide will help you explore both the opportunities and limitations of this rapidly evolving field.
Biotechnology is one of those subjects that sounds exciting from a distance and confusing up close. Students wonder whether the degree is worth the money. Graduates wonder why nobody will hire them without experience. Career changers wonder if they are too late. And curious readers just want to know why a field that promises to cure disease and feed the world still feels so hard to understand.
This guide goes through the problems people search for most often and answers each one in plain language. In Batch 1 we cover the confusion about what biotechnology even is, how it differs from similar fields, whether the degree pays off, what jobs and salaries look like in 2026, why entry level roles are so hard to land, and why drugs take so long and cost so much. Batch 2 will cover ethics, regulation, funding, skills, and where the field is heading.
Problems and Challenges of Biotechnology: 15 Major Disadvantages, Ethical Issues, Risks and Solutions Explained
Problem 1: “I still do not understand what biotechnology actually is”
This is the first wall most people hit. Ask five people to define biotechnology and you will get five different answers, usually involving DNA, vaccines, or genetically modified crops. They are all partly right.
In simple terms, biotechnology means using living organisms, or parts of them such as cells and enzymes, to make products or solve problems. People have done this for thousands of years. Brewing beer, baking bread, and making cheese all rely on microbes. What changed in the last fifty years is that scientists learned to read and edit DNA directly, which turned an old craft into a precision industry.
The reason it feels confusing is that the field is huge. It touches medicine, farming, food, energy, and environmental cleanup. Scientists sort it into color coded branches, and knowing them makes the whole subject easier to navigate.
| Branch | What it focuses on | Everyday example |
|---|---|---|
| Red biotechnology | Health and medicine | Vaccines, insulin, gene therapies |
| Green biotechnology | Agriculture and plants | Drought tolerant crops, pest resistant seeds |
| White biotechnology | Industry and manufacturing | Enzymes in detergents, biofuels |
| Blue biotechnology | Marine and aquatic life | Compounds from sea organisms, aquaculture |
| Yellow biotechnology | Food production | Fermented foods, improved yeast |
| Grey biotechnology | Environment | Cleaning polluted soil and water |
If you are still unsure where you fit, start with the branch that connects to something you already care about. A person who likes medicine will feel at home in red biotechnology. Someone who grew up on a farm may find green biotechnology far more interesting.
Problem 2: “Is biotechnology the same as biomedical science, bioengineering, or microbiology?”
This question gets searched constantly, and it is a real source of stress, because choosing the wrong degree can cost years. The fields overlap, but they are not identical.
| Field | Main focus | Typical work |
|---|---|---|
| Biotechnology | Applying living systems to make products and tools | Lab research, product development, quality control |
| Biomedical science | Understanding human health and disease | Diagnostics, clinical labs, medical research |
| Bioengineering | Designing devices and systems using engineering principles | Prosthetics, medical devices, tissue engineering |
| Microbiology | Studying microorganisms | Infection research, food safety, industrial microbiology |
| Biochemistry | Chemical processes inside living things | Drug discovery, protein research |
A quick way to decide: if you enjoy building and designing, look at bioengineering. If you want to understand disease, biomedical science fits. If you want to turn biological ideas into real products and processes, biotechnology is the closest match. Biochemistry sits underneath all of them, so it is a safe foundation if you are unsure.
The good news is that these paths are not locked in. Many people start in one field and move into another through a master’s degree or on the job. What matters more than the label on your degree is the hands on skills you can show.
Problem 3: “Is a biotechnology degree worth it?”
This is probably the most emotional question on the list, and it deserves a straight answer rather than a sales pitch.
A biotechnology degree can be worth it, but it is not a guaranteed ticket to a good job. The value depends heavily on three things: how much practical lab experience you gather, which level of degree you hold, and where you plan to work.
A bachelor’s degree opens the door to technician and research associate roles. A master’s degree improves your chances for specialist and quality roles. A PhD is usually needed if you want to lead research, though it takes many years and the payoff varies.
The part that worries people is the job market, so let us look at it honestly. Biotechnology went through a rough patch recently. Biopharma layoffs rose 47.1 percent year over year in 2025, from 29,017 to 42,701. That is a big jump, and it hit many experienced workers.
But 2026 has looked better. By the second quarter of 2026, the number of companies cutting or planning to cut jobs fell 59 percent compared with the same quarter a year earlier, and job postings on BioSpace rose 15 percent year over year. Money is also flowing back in. Venture funding reached $29.9 billion in the first half of 2026, up 30 percent from a year earlier and the highest in four years.
So the honest summary is this: the field is recovering, but it has not fully bounced back. Overall postings were still 14% below the 2024 level at the end of 2025. If you enter with a clear plan and real skills, the degree can pay off. If you assume the certificate alone will do the work, you may be disappointed.
A simple test before you commit
Ask yourself these questions before enrolling:
- Can I find at least three people with this degree who are working in jobs I would want?
- Does the program offer lab placements, internships, or research projects?
- Am I willing to build skills outside class, such as data analysis or lab techniques?
- Can I afford it without relying on a guaranteed high salary right after graduation?
If most of your answers are yes, the degree is a reasonable bet.
Problem 4: “What do biotechnology jobs actually pay?”
Salary is the second most searched worry, and most online answers are either vague or wildly optimistic. Pay depends on your role, your location, and the type of employer.
At the entry level, expect modest pay. In one of the most expensive biotech hubs, a true entry level Research Associate I in Boston or Cambridge usually lands around $58,000 to $70,000, and strong internship experience can push that closer to $70,000 to $75,000. Those are US figures in a high cost city, so salaries in smaller markets or other countries will differ.
Pay grows quickly in specialized and data focused roles. In computational biology, one job board that tracked 631 postings in the second quarter of 2026 reported an average salary floor of $148,000, up 9 percent from the previous quarter. That is a very different world from lab technician pay, and it shows why many people now add programming and data skills to their biology training.
Here is a rough way to think about the ladder:
- Lab technician or research associate: the starting point, usually the lowest pay
- Scientist or quality specialist: a step up, often needing a master’s degree or several years of experience
- Senior scientist or manager: requires proven results and often leadership ability
- Computational or data roles: frequently the highest paid, but demand strong technical skills
If you are outside the US, check local salary data rather than relying on American numbers. A strong pay figure in Boston may not translate to Lagos, London, or Toronto.
Problem 5: “Why can’t I get an entry level job with no experience?”
This is the frustration that fills forums and comment sections. Job posts for “entry level” roles ask for two years of experience, specific lab techniques, and sometimes a publication. It feels like a trap.
The problem is real. In a BioSpace survey, some respondents described difficulty finding entry level positions, with one calling it almost impossible for a new person to break into the industry. Part of the issue is competition. Some of the competition for open positions has come from unemployed biopharma professionals pushed into the market by layoffs. When experienced people apply for junior roles, newcomers get squeezed out.
The good news is that the squeeze is easing as hiring picks up, and there are practical ways to get around the experience trap. Here is a step by step approach that works for many graduates.
How to break into biotechnology without experience
- Turn coursework into proof. List the exact techniques you have used, such as PCR, cell culture, or gel electrophoresis, and how often. Hiring managers want specifics, not general claims.
- Get any lab time you can. Volunteer in a university lab, take a summer research placement, or work as a lab assistant. Even a few months counts.
- Learn one data skill. Basic Python, R, or statistics sets you apart because many labs struggle to find people who can analyze their own results.
- Aim at the right employers. Contract research organizations, manufacturing sites, and quality control labs hire more juniors than flashy startups do.
- Network with intention. Message people who hold the job you want, ask one specific question, and be respectful of their time. Many hires happen through referrals.
- Tailor each application. Match your resume to the wording in the job post. Hiring managers have said they want detailed resumes that clearly show what you did.
- Be open to adjacent roles. Quality assurance, regulatory support, and clinical operations can lead to research later, and they often hire people with less experience.
This path takes patience. It can take months, and rejection is normal. But it is far more effective than sending the same generic resume to a hundred listings.
Problem 6: “Why does it take so long and cost so much to develop biotech drugs?”
If you read the news, you have seen headlines about expensive medicines and treatments that take over a decade to reach patients. People search this question because the numbers feel absurd, and they want to know whether it is greed, bad management, or something deeper.
The truth is a mix, but a lot of it comes down to how hard biology is and how carefully medicines must be tested.
Here is the usual journey of a new drug:
- Discovery. Scientists identify a biological target, such as a protein involved in a disease, and search for a molecule that can affect it.
- Preclinical testing. The candidate is tested in cells and animals to check basic safety and whether it seems to work.
- Phase 1 trials. A small group of people receive the drug to check safety and dosage.
- Phase 2 trials. A larger group tests whether it works and continues to monitor side effects.
- Phase 3 trials. Hundreds or thousands of patients are enrolled to confirm results against existing treatments.
- Regulatory review. Authorities such as the FDA examine all the data before approving the drug.
- Monitoring after launch. Safety tracking continues once the drug is on the market.
Each stage can take years, and most candidates fail along the way. That last point matters most. Companies spend money on many drugs that never reach approval, and the cost of those failures is folded into the price of the few that succeed. Widely quoted estimates put a full development effort at roughly a decade or more and billions of dollars, though the exact figures vary a lot depending on the study and the type of drug.
Biotechnology medicines add another layer of expense because they are often made inside living cells. Growing consistent batches of such products is far more delicate than mixing chemicals, so manufacturing itself is costly.
None of this means the system is perfect or that prices are always fair. It does mean that the slow pace is not just bureaucracy. Safety testing exists because mistakes in medicine can cost lives, and biology rarely behaves as predicted.
What to take away....
If you are feeling overwhelmed, here are the key points in short form:
- Biotechnology is a broad field built around using living systems to solve problems, and it is easier to understand when you look at its branches.
- Related degrees overlap, but your hands on skills matter more than the exact title on your certificate.
- The job market is recovering in 2026 after a painful 2025, so choose your path with open eyes.
- Entry level pay is modest, while data and computational skills can lift your earning potential.
- Breaking in without experience is hard, but a deliberate plan makes it much more doable.
- Drug development is slow and costly because biology is complex and safety comes first.
Biotechnology Problems and Challenges: The Most Searched Questions, Answered (Batch 2)
Batch 1 covered the basics, the degree question, jobs, pay, entry level barriers, and drug costs. Batch 2 moves into the harder topics: ethics, food safety fears, regulation, startup struggles, learning skills on your own, biotechnology in Africa, and the rise of artificial intelligence. It ends with a FAQ and a practical action plan.
Problem 7: “Is gene editing ethical, and where is the line?”
Few biotechnology topics cause more worry than gene editing. People search for it because the technology feels powerful and a little frightening. Tools like CRISPR let scientists cut and change DNA with far more precision than older methods, and that precision raises serious questions.
It helps to separate two very different uses.
Somatic gene editing changes the DNA in a patient’s body cells to treat a disease. The changes affect only that person and are not passed to children. This is the kind already moving into clinics. The first CRISPR based therapy for sickle cell disease and a related blood disorder received approval in late 2023, which was a landmark moment for the field.
Germline editing changes DNA in embryos, eggs, or sperm, so the edits can be inherited by future generations. This is where the strongest ethical objections sit. Most countries restrict or ban it, and the scientific community widely condemned the 2018 case in which a researcher announced the birth of gene edited babies.
The main ethical concerns people raise fall into a few groups:
- Safety. Edits can sometimes land in the wrong place, causing unintended changes, and long term effects are hard to predict.
- Fairness. If treatments cost hundreds of thousands of dollars, only wealthy patients may benefit.
- Enhancement. Treating disease is one thing, but choosing traits such as height or intelligence is another, and many people see that as a line that should not be crossed.
- Consent. Future generations cannot agree to changes made to their DNA.
There is no single global answer, and reasonable people disagree. A helpful rule many ethicists use is to ask whether the edit treats a serious illness, whether safer alternatives exist, and whether the risks are clearly understood and fairly shared. If you are writing or studying this topic, present several viewpoints rather than only the loudest ones.
Problem 8: “Are GMO foods safe to eat?”
This is one of the oldest and most searched biotechnology questions, and it is also one of the most emotionally charged. Many people want a clear yes or no, and the real answer needs a little more care.
Here is where the evidence stands. Major scientific bodies, including the US National Academies of Sciences in a large 2016 review, have concluded that genetically engineered foods currently on the market are not shown to be less safe to eat than their conventional counterparts. The World Health Organization has said similar things about approved GM foods, while noting that each product should be assessed individually before it reaches shoppers.
That last part is the key. “GMO” is not one thing. A crop engineered to resist an insect is different from one engineered to tolerate a herbicide, and both differ from a rice variety enriched with vitamin A. Safety checks happen product by product, not for the whole category at once.
So why does the worry persist? A few reasons come up again and again:
- Trust in companies. Some people are uneasy about large corporations controlling seeds and patents, and that distrust gets mixed up with safety questions.
- Environmental concerns. Questions about herbicide use, pesticide resistance, and effects on biodiversity are separate from food safety, and they are debated seriously.
- Labeling and transparency. When people feel they are not told what is in their food, suspicion grows.
- Misinformation. Viral claims, often with no data behind them, spread faster than careful reviews.
A fair summary is that the food safety evidence for approved GM crops is reassuring, while the economic and environmental debates are legitimate and still open. If you want to check a specific product, look at the approval documents published by the relevant national regulator rather than relying on social media posts.
Problem 9: “Why is biotechnology regulation so confusing?”
Anyone who tries to launch a biotechnology product quickly runs into a maze of rules. Regulation differs by country, by product type, and sometimes by the exact method used to make the product. For founders and students, this is a major pain point.
Here is a simplified look at who handles what in a few major regions. These are broad outlines, and you should confirm details with the official source.
| Region | Main bodies involved | What they usually oversee |
|---|---|---|
| United States | FDA, USDA, EPA | Medicines and devices, plants and animals, pesticides and environmental effects |
| European Union | EMA, EFSA | Medicines, food and feed safety |
| United Kingdom | MHRA, Food Standards Agency | Medicines, food products |
| Nigeria | NAFDAC, NBMA | Food and drugs, biosafety of modified organisms |
The confusion usually comes from three sources. First, products can fall under more than one agency. A gene edited crop, for example, may touch agriculture, food, and environmental rules. Second, rules keep changing as the science moves forward, and regulators sometimes lag behind. Third, each country draws its own lines, so a product approved in one place may face a very different process elsewhere.
If you are building a product, here is a sensible way to handle it:
- Identify your product category early. Is it a drug, a device, a food, a crop, or something else?
- Find the lead regulator for that category in your target market. Their website usually explains the process and lists contacts.
- Ask for early guidance. Many agencies offer pre submission meetings, which can save months of wasted effort.
- Plan documentation from day one. Keep careful records of experiments, batches, and safety data, because you will need them later.
- Budget time and money for the process. Approval timelines are rarely quick, so build them into your plan.
Regulation can feel like an obstacle, but its purpose is to protect people. Teams that treat it as a design requirement from the start usually move faster than those who treat it as paperwork at the end.
Problem 10: “Why do so many biotech startups fail?”
Biotechnology startups attract huge attention and huge risk. People search for this because they want to know whether starting a company is realistic, or whether they are better off joining an existing one.
The honest picture is that biotechnology is expensive and slow, which makes survival difficult. Several problems come up repeatedly:
- Long timelines with no revenue. A company may spend years on research before earning anything, so it depends on investors staying patient.
- High failure rates. Many promising ideas fail in testing, often after large amounts of money have already been spent.
- Funding swings. Investor interest rises and falls with market conditions, and when money gets tight, early stage companies feel it first.
- Talent and equipment costs. Specialized people, lab space, and instruments are pricey, particularly in major hubs.
- Regulatory uncertainty. Delays in approval can drain a young company’s runway.
None of this means startups never succeed. It means that success usually depends on a few things going right at once: a strong scientific idea, a team that can execute, enough funding to survive setbacks, and a clear path to a real customer or patient need.
If you are considering founding a company, try this short test:
- Does your idea solve a real problem that people will pay to fix?
- Can you reach a meaningful milestone in two to three years with the money you can raise?
- Do you have, or can you recruit, people who cover science, business, and regulation?
- Have you explored partnerships, grants, or university programs that reduce costs?
Not every biotechnology career needs to involve starting a company. Many people do their best work inside established organizations, where they can learn without carrying the financial risk personally.
Problem 11: “How can I learn biotechnology skills without access to a lab?”
This question comes up a lot, especially from students in places where lab access is limited. Hands on training is important, but you can still build a strong foundation before you step into a lab.
Here is a step by step plan for learning at home.
- Master the fundamentals. Study molecular biology, genetics, and biochemistry. Free university courses and open textbooks cover these well.
- Learn how common lab techniques work. Read protocols and watch demonstration videos for methods such as PCR, cloning, gel electrophoresis, and cell culture. You will not practice them, but you will understand the logic behind them.
- Pick up data skills. Learn basic statistics, then try Python or R. Practice with free public datasets.
- Try bioinformatics. Public databases let you explore real DNA and protein sequences from your laptop, which is useful experience for modern roles.
- Use virtual labs and simulations. Some universities offer online simulations that let you practice procedures and experiment design.
- Read recent research. Start with review articles, then move to original papers. Summarize each one in your own words to check that you understand it.
- Document your learning. Keep a simple portfolio of projects, analyses, and notes. A hiring manager can see that you have initiative.
- Look for in person chances. Short courses, workshops, volunteering in a local university lab, or industry internships will give you the hands on time you need.
A word of caution on home experiments. Keep biology projects within safe, legal limits and do not attempt to work with pathogens or genetic modification outside a proper facility. Learning concepts and data skills at home is great. Working with living organisms requires training, oversight, and the right equipment.
Problem 12: “What are the challenges of biotechnology in Africa and other emerging regions?”
This is a question many readers in Nigeria and across the continent search for, and it deserves a serious answer. Africa has enormous potential in agriculture, health, and environmental biotechnology, but it faces specific barriers.
The common challenges include:
- Limited funding. Research budgets are often small, and long term support is hard to find.
- Infrastructure gaps. Reliable electricity, cold storage, and modern lab equipment are not always available, and these are basic needs for biological work.
- Brain drain. Skilled scientists often leave for better paid opportunities abroad, which weakens local research.
- Regulatory capacity. Some countries have newer biosafety systems that are still being built, which can slow approvals.
- Public understanding. Misinformation and low awareness can create fear, which affects acceptance of new products.
- Weak links between research and industry. Good ideas from universities do not always reach commercial production.
There are also encouraging signs. Several African countries have approved biotechnology crops in recent years, including Nigeria, which has approved improved varieties aimed at helping farmers cope with pests and drought. Local startups are working on diagnostics, agricultural tools, and affordable health products. Regional collaboration and international partnerships are also growing.
If you live in a region with these challenges, you can still build a strong career. Look for programs that offer remote collaboration, apply for international fellowships and scholarships, focus on problems that matter locally such as crop diseases or tropical infections, and build skills that travel well, like data analysis. Many of the most valuable biotechnology solutions for Africa will come from people who understand the problems firsthand.
Problem 13: “How is artificial intelligence changing biotechnology, and will it take jobs?”
AI is the newest worry on the list, and it is also one of the biggest opportunities. People want to know whether it will replace scientists or make them more productive.
In practice, AI is already helping in several areas. It can predict protein structures, which speeds up the early stages of drug discovery. It can scan huge datasets to find patterns that humans might miss. It can help design experiments, flag likely failures, and sort through scientific papers. These tools can save time and money, and they are one reason demand for computational skills is rising.
But AI does not remove the need for laboratory work or human judgment. A prediction still has to be tested in real cells, real animals, and eventually real patients. Someone has to decide which questions matter, check results, and take responsibility for safety. Biology is messy, and models are only as good as the data they learn from.
The likely effect on jobs is a shift rather than a wipeout. Routine, repetitive tasks may become more automated, while people who can combine biology with data skills become more valuable. That matches the salary pattern we saw in Batch 1, where computational roles tended to pay more.
To stay ahead, consider this plan:
- Learn the basics of programming and statistics.
- Understand how machine learning works at a high level, even if you never build models yourself.
- Practice working with real biological data.
- Keep strengthening your core biology and lab knowledge, because AI tools need people who can interpret results.
- Stay curious and update your skills every year.
Frequently asked questions
Is biotechnology a good career choice in 2026?
It can be, particularly if you build practical and data skills. The market has been recovering after a tough 2025, but competition for entry level roles is still strong, so preparation matters.
What is the easiest way to start in biotechnology?
Start with a solid foundation in biology and chemistry, get any lab experience you can, and learn at least one data skill. Quality control, manufacturing, and clinical support roles often have lower barriers to entry.
Do I need a PhD to work in biotechnology?
No. Many roles are open to people with a bachelor’s or master’s degree. A PhD is mainly needed for leading independent research, and it is a major time and financial commitment.
Is biotechnology only for people who like labs?
Not at all. The industry also needs data analysts, regulatory specialists, project managers, writers, business developers, and policy experts.
Can I work in biotechnology with a non biology degree?
Yes. People with backgrounds in computer science, engineering, chemistry, and business often move into the field, especially into data and operations roles.
Is biotechnology dangerous?
Biotechnology work is governed by safety rules to manage risks, and regulated facilities follow strict procedures. Like any science, it has risks, but oversight exists to reduce them.
How long does it take to get a job after graduating?
It varies widely. Some graduates land roles within a few months, while others need longer, especially without internships. Building experience before you graduate shortens the search.
What is the best country to study biotechnology?
There is no single best place. The United States, the United Kingdom, Germany, Canada, and Singapore are popular because of their research strength and industry links. Choose based on the program, funding, and the career you want.
Your action plan
If you want to move forward after reading this guide, here is a simple checklist.
- Choose your branch. Decide which part of biotechnology interests you most: health, agriculture, industry, food, or environment.
- Build your base. Strengthen your biology, chemistry, and statistics knowledge.
- Get hands on. Seek labs, internships, and short courses as early as possible.
- Add one data skill. Python, R, or bioinformatics will set you apart.
- Create a portfolio. Document your projects and learning.
- Network carefully. Reach out to professionals with specific, respectful questions.
- Apply strategically. Tailor each application and target employers that hire juniors.
- Keep learning. The field changes fast, so make learning a habit.
In Consclusion
Biotechnology is full of real problems: confusing definitions, tough entry level hiring, expensive drug development, ethical debates, tricky regulation, and uneven access around the world. But those problems exist because the field matters. It touches health, food, energy, and the environment, and it needs thoughtful people who can handle both the science and the questions it raises.
The best approach is to stay realistic and stay curious. Understand the challenges, build skills that employers want, and focus on problems you actually care about. The people who thrive in biotechnology are rarely the ones who expected it to be easy. They are the ones who kept learning when it was not.
Biotechnology has enormous potential to transform healthcare, agriculture, industrial production and environmental management. However, its development also comes with significant challenges that cannot be ignored. From ethical controversies and environmental concerns to high research costs, regulatory difficulties, biological safety and unequal access to advanced technologies, these problems demonstrate why biotechnology must be developed and applied responsibly.
One important lesson is that scientific advancement should always be accompanied by appropriate safety measures, ethical standards, effective regulation and public awareness. Governments, researchers, universities, biotechnology companies and international organisations all have important roles to play in addressing these challenges. Strong regulatory systems, transparent research practices, responsible innovation and continued scientific assessment can help reduce potential risks while allowing society to benefit from biotechnology.
It is also important to recognise that the challenges of biotechnology do not mean that scientific progress should be discouraged. Instead, they highlight the need to improve research methods, strengthen biosafety practices, make biotechnology more affordable and ensure that its benefits are accessible to different communities, particularly in developing countries.
Ultimately, the future of biotechnology will depend not only on what scientists can achieve but also on how responsibly these discoveries are developed and used. By understanding its problems, limitations and possible solutions, society can make better decisions about the role biotechnology should play in improving human health, food security, economic development and environmental sustainability.

Comments
Post a Comment